Leading Wound Care Billing Services in Pennsylvania

Wound care billing services in Pennsylvania are navigating one of the most demanding reimbursement environments in the country right now. Pennsylvania sits under Novitas Solutions’ JH/JL MAC jurisdiction — and Novitas is actively conducting Targeted, Probe and Educate audits on skin substitute claims. The CY 2026 Physician Fee Schedule Final Rule (CMS-1832-F) reset non-biological skin substitute reimbursement to a flat rate of $127.14 per square centimeter.

And Highmark — the dominant commercial payer across western and central Pennsylvania — adopted the CMS flat-rate pricing methodology for non-BLA skin substitutes effective January 1, 2026, for both Medicare Advantage and commercial plans.

If your practice is applying cellular tissue products for diabetic foot ulcers or venous leg ulcers without a Novitas-specific documentation workflow, the revenue exposure is real and it’s growing with every claim cycle.

What Sets Pennsylvania Wound Care Billing Apart

Pennsylvania is not a simple billing market for wound care. It has three dominant commercial payers — Highmark in western and central Pennsylvania, Independence Blue Cross in the Philadelphia metro, and UPMC Health Plan in Pittsburgh — each with distinct prior authorization requirements, documentation standards, and skin substitute reimbursement policies.

It has a large Medicare and Medicaid population across rural Appalachian communities in the central and northeastern regions. And it sits under Novitas, one of the most actively auditing MACs in the country for wound care claims.

Pennsylvania wound care billing also requires managing a payer-specific product approval split that most practices aren’t tracking at the claim level. Highmark reimburses BLA-approved skin substitutes under ASP+6% methodology while applying CMS flat-rate pricing for non-BLA products.

Independence Blue Cross and UPMC Health Plan each maintain their own coverage criteria for cellular and tissue-based products. Treating these payers identically on skin substitute claims generates systematic revenue leakage on every application.

That’s the environment Pennsylvania wound care billing services need to be built for. Not general medical billing services adapted from other specialties. Purpose-built wound care RCM services calibrated for Novitas LCD compliance and Pennsylvania’s commercial payer landscape.

The Triple Threat to Pennsylvania Wound Care Revenue in 2026

Three billing failures compound each other across Pennsylvania wound care practices right now. Each one is preventable. Together, they typically represent $100,000 to $280,000 in recoverable annual revenue.

1. Skin Substitute Documentation Gaps Under Novitas LCD L35041

Novitas’s existing LCD L35041 remained active following CMS’s December 24, 2025 withdrawal of the proposed replacement LCDs. That means Pennsylvania providers still operate under its documentation requirements — and Novitas’s TPE auditors are checking compliance against those exact criteria.

What does L35041 require? Four weeks of documented conservative treatment failure before any CTP application. Wound measurements consistent across visits. A vascular assessment for diabetic foot ulcer and venous leg ulcer cases — including an Ankle-Brachial Index of at least 0.60 for DFU patients.

And the physician managing the patient’s underlying condition — diabetes or venous disease — must be documented in the clinical record at the time of application. A single missing element in that documentation chain doesn’t just risk one claim. It puts the entire episode of care under review.

2. ICD-10 Depth-Coding Errors on Post-Surgical Wound Claims

This one catches Pennsylvania practices off guard every billing cycle. ICD-10 code T81.32XA was deleted and replaced with a series of depth-specific codes — T81.320A (deep internal surgical wound disruption), T81.321A (superficial), T81.322A (intraabdominal), and T81.329A (unspecified). Every code carries initial, subsequent, and sequela encounter designators.

Claims still carrying T81.32XA deny automatically. For practices treating post-surgical dehiscence — a high-volume encounter type in Pennsylvania’s large academic medical center and regional hospital networks — this error generates silent write-offs at scale. Correcting it requires not just a code update but a clinical documentation workflow that captures wound depth at every encounter.

3. NPWT Equipment Type Misclassification

Negative pressure wound therapy billing splits on equipment type, not wound type. Reusable DME pump cases bill under CPT 97605 (≤50 sq cm) or 97606 (>50 sq cm) — and the pump and supplies route to the DME MAC separately. Disposable single-use device cases bill under CPT 97607 (≤50 sq cm) or 97608 (>50 sq cm) — an all-inclusive payment covering the device, supplies, and service in one.

Filing the wrong NPWT code for the equipment type used generates either a denial or a payment at the wrong rate. Practices without an equipment-type verification step embedded in their coding workflow make this error on a percentage of cases every month. Across a high-volume wound care practice in Philadelphia or Pittsburgh, that percentage adds up to real money.

What MBC Delivers for Pennsylvania Wound Care Practices

MBC operates a dedicated wound care billing operation — coders trained specifically on Novitas LCD L35041 requirements, Pennsylvania commercial payer documentation standards, and the full CPT spectrum for wound care services. Pennsylvania wound care billing services from MBC function as a revenue integrity partner, not a claim processor.

Pennsylvania wound care billing with MBC delivers an average 20% improvement in Net Collection Ratio within the first two billing cycles. The recovery comes from documentation gaps closed, ICD-10 errors corrected, and NPWT routing fixed — revenue your clinical team already earned.

Pennsylvania Markets MBC Serves

Our wound care billing services in Pennsylvania cover every major market in the state. Whether your practice is in Philadelphia’s dense urban wound care corridor or a rural community in central or eastern Pennsylvania, we are actively managing claims in these cities and surrounding areas:

Philadelphia — Pittsburgh — Allentown — Erie — Reading — Scranton — Bethlehem — Lancaster — Harrisburg — Wilkes-Barre — York — State College — Altoona — Easton — Lebanon — Williamsport — Hazleton — New Castle — McKeesport — Pottstown — Chester — Norristown — Kingston — Hermitage — Sharon — Oil City — Meadville — Carbondale — Stroudsburg — Sunbury — Lewistown — Bloomsburg — Chambersburg — Gettysburg — Waynesboro — Coatesville — West Chester — Doylestown — Phoenixville — Pottsville — Johnstown — Butler — Greensburg — Washington — Uniontown — Connellsville — Bradford — DuBois — Punxsutawney — Lock Haven

From Philadelphia’s academic medical center wound care programs and Independence Blue Cross payer environment, to Pittsburgh’s UPMC Health Plan market, to rural Pennsylvania communities where Medicaid managed care complexity is highest — if you’re treating wound care patients in Pennsylvania, we know your market.

Request Your Complimentary 90-Day Revenue Diagnostic

Most Pennsylvania wound care practices that engage MBC discover between $100,000 and $280,000 in recoverable annual revenue during the first audit. We review your last 90 days of claims against Novitas LCD L35041 requirements.

We identify skin substitute claims missing documentation elements. We flag ICD-10 depth-coding errors on post-surgical wound encounters. We audit your NPWT equipment routing. And we calculate your actual NCR against Pennsylvania specialty benchmarks.

No commitment required. Just a clear, honest picture of what your practice is currently leaving uncollected.

Request Your 90-Day Revenue Diagnostic.

Call: 888-357-3226 | Email: info@medicalbillersandcoders.com 

FAQs